Lipotoxicity contributes to endothelial dysfunction: a focus on the contribution from ceramide.

Area of Science:

• Cardiovascular research
• Metabolic syndrome
• Endothelial biology

Background:

• Cardiovascular complications are the primary cause of death in obesity, type 2 diabetes mellitus (T2DM), and insulin resistance.
• These complications affect both large (atherosclerosis, cardiomyopathy) and small (retinopathy, nephropathy, neuropathy) vessels.
• Endothelial dysfunction, marked by reduced nitric oxide (NO) bioavailability, is a common feature.

Purpose of the Study:

• To review the contribution of elevated circulating fatty acids to lipotoxicity in obesity, T2DM, and insulin resistance.
• To examine the role of specific fatty acid metabolites, particularly ceramide.
• To understand the mechanisms linking metabolic disturbances to endothelial dysfunction.

Main Methods:

• Literature review focusing on the impact of hyperglycemia, oxidative stress, renin-angiotensin system activation, and inflammation on NO bioavailability.
• Analysis of studies investigating the effects of elevated fatty acids and lipotoxicity on endothelial cells.
• Examination of research on ceramide metabolism and its role in cardiovascular pathology.

Main Results:

• Systemic disturbances like hyperglycemia, oxidative stress, and inflammation exacerbate endothelial dysfunction by reducing NO bioavailability.
• Elevated circulating fatty acids contribute to lipotoxicity, further impairing endothelial function.
• Ceramide, a key fatty acid metabolite, plays a significant role in mediating lipotoxicity and endothelial dysfunction.

Conclusions:

• Elevated fatty acids and resulting lipotoxicity, particularly involving ceramide, are critical contributors to cardiovascular complications in obesity, T2DM, and insulin resistance.
• Targeting lipotoxicity and ceramide metabolism may offer therapeutic strategies for preventing cardiovascular disease in these patient populations.
• Understanding the interplay between metabolic disturbances and endothelial dysfunction is crucial for managing cardiovascular risk.